Zuopeng Wang Selected Research

Kaposiform Hemangioendothelioma

1/2023	Case Report: Kaposiform hemangioendothelioma with PIK3CA mutation successfully treated with sirolimus.
7/2021	Overexpression Prox1 in HemECs resembles Kaposiform hemangioendothelioma and cytotoxicity of sirolimus in vitro.
5/2021	Comparison of efficacy and safety of corticosteroid and vincristine in treating kaposiform hemangioendothelioma and tufted angioma: A multicenter prospective randomized controlled clinical trial.
7/2020	Retroperitoneal kaposiform hemangioendothelioma complicated by Kasabach-Merritt phenomenon and obstructive jaundice: A retrospective series of 3 patients treated with sirolimus.
1/2020	Immunohistochemical Analysis of mTOR Pathway-Related Proteins in Kaposiform Hemangioendothelioma.
11/2019	Sirolimus therapy for kaposiform hemangioendothelioma with long-term follow-up.
10/2019	Comparison of Corticosteroid and Vincristine in Treating Kaposiform Hemangioendothelioma and Tufted Angioma: A Systematic Review and Meta-Analysis.
4/2015	Steroid-resistant kaposiform hemangioendothelioma: a retrospective study of 37 patients treated with vincristine and long-term follow-up.
1/2015	Successful treatment of Kasabach-Merritt phenomenon arising from Kaposiform hemangioendothelioma by sirolimus.
8/2014	Variable response to propranolol treatment of kaposiform hemangioendothelioma, tufted angioma, and Kasabach-Merritt phenomenon.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Zuopeng Wang Research Topics

Disease

11	Neoplasms (Cancer) 07/2023 - 04/2015
11	Kaposiform Hemangioendothelioma 01/2023 - 03/2014
4	Neuroblastoma 01/2021 - 08/2016
4	Kasabach-Merritt Syndrome 07/2020 - 08/2014
3	Tufted angioma 05/2021 - 08/2014
2	Neoplasm Metastasis (Metastasis) 12/2019 - 03/2019
1	Contracture 07/2023
1	Pain (Aches) 07/2023
1	Vascular Malformations 07/2023
1	Carcinogenesis 03/2022
1	Thrombocytopenia (Thrombopenia) 05/2021
1	Obstructive Jaundice (Cholestatic Jaundice) 07/2020
1	Tuberous Sclerosis (Bourneville's Disease) 01/2020
1	Intra-Abdominal Hypertension 12/2019
1	Infections 11/2019
1	Anemia 11/2019
1	Disease Progression 07/2015
1	Pleural Effusion (Pleural Effusions) 07/2015

Drug/Important Bio-Agent (IBA)

9	Sirolimus (Rapamycin)FDA Link 07/2023 - 03/2014
4	Vincristine (Oncovin)FDA LinkGeneric 05/2021 - 04/2015
3	Adrenal Cortex Hormones (Corticosteroids)IBA 05/2021 - 03/2019
2	Phosphoric Monoester Hydrolases (Phosphatases)IBA 01/2020 - 06/2017
2	TensinsIBA 01/2020 - 06/2017
2	TOR Serine-Threonine KinasesIBA 01/2020 - 11/2019
2	SteroidsIBA 04/2015 - 04/2015
1	NucleolinIBA 03/2022
1	Transcription Factors (Transcription Factor)IBA 03/2022
1	Biomarkers (Surrogate Marker)IBA 03/2022
1	Therapeutic UsesIBA 05/2021
1	Fibrinogen (Factor I)FDA Link 05/2021
1	Circular RNAIBA 01/2021
1	betaglycan (TGFBR3)IBA 01/2021
1	RNA (Ribonucleic Acid)IBA 01/2021
1	Peptide Initiation Factors (Initiation Factor)IBA 01/2020
1	MTOR InhibitorsIBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020
1	Ribosomal Protein S6 Kinases (S6 Kinase)IBA 01/2020
1	Carrier Proteins (Binding Protein)IBA 01/2020
1	Long Noncoding RNAIBA 12/2019
1	Hemoglobins (Hemoglobin)IBA 11/2019
1	Hormones (Hormone)IBA 03/2019
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 03/2019
1	MicroRNAs (MicroRNA)IBA 06/2017
1	Immunotoxins (Immunotoxin)IBA 08/2016
1	Cell Surface ReceptorsIBA 08/2016
1	ErbB Receptors (EGF Receptor)IBA 08/2016
1	Propranolol (Inderal)FDA LinkGeneric 08/2014

Therapy/Procedure

4	Therapeutics 07/2023 - 07/2015
1	Aftercare (After-Treatment) 07/2023
1	Drug Therapy (Chemotherapy) 12/2019
1	Laparotomy 03/2019